page

alaabta

CAS 112809-51-5 Anti Estrogen Steroid Powder White Henlthy Letrozole Femara ee Kansarka Naaska

Sharaxaad Gaaban:


Faahfaahinta Alaabta

Tags Product

Faahfaahin Degdeg ah

CAS: 112809-51-5

La mid ah: FEMARA;CGS-20267;LETROZOL;LETROZOLE;LetrozoleUsp28;Letrozole99%;CGS-20267,Femara

daahirnimo:99%

Muuqaal: Caddaan ama crystal jaale fudud

Qaacidada unugyada: C17H11N5

Miisaanka Molecular: 285.31

Meesha dhalaalaysa: 181°C ~ 183°C

Steroids-ka-hortagga Estrogen-ka Jirdhiska Letrozole Femara White Powder CAS 112809-51-5

1

Isticmaalka: Waxa loo isticmaalaa API ahaan daawaynta cudurka naaska.

Qiyaasta lagu taliyey ee Femara waa hal kiniin oo 2.5 mg ah oo la maamulo hal mar maalintii, iyada oo aan loo eegin cuntada.

Letrozole waxay hoos u dhigtaa heerarka estrogen ee haweenka postmenopausal, taas oo laga yaabo inay hoos u dhigto koritaanka noocyada qaar ee burooyinka naaska kuwaas oo u baahan estrogen si ay ugu koraan jirka.

Cuntada Letrozole

qiyaas maaddo
1 garaam Budada Letrozole
19.9 ml PEG 300
179.1 ml 190 Caddayn Khamriga Hadhuudhka

Qaadashada Letrozole/Femara

Isticmaalayaasha anecdotally ayaa sheegay inay arkeen natiijooyin wanaagsan iyagoo isticmaalaya qiyaaso u dhexeeya qiyaastii .25mgs maalintii ilaa .5mgs maalintii.Si kastaba ha ahaatee qiyaasahani aad bay ugu kala duwan yihiin isticmaale ilaa isticmaale, oo ay ku jiraan jadwalka qiyaasta.Qaar ka mid ah ayaa soo sheegay isticmaalka xarunta maalin kasta ama maalin kasta oo seddexaad ah oo leh natiijooyin wanaagsan.Sidoo kale, qiyaasaha la soo sheegay ayaa u dhexeeyay .25mgs ilaa 2.5mgs maalintii.

Wixii ku saabsan qaadashada, waxaad u baahan tahay inaad samayso doorasho lagu daro xaaladda jidhkaaga, ama la tasho tababarahaaga / dhakhtarkaaga.Maqaalkani waa tixraac kaliya.

Saamaynta Letrozole/Femara

Letrozole ee bukaannada postmenopausal ee qaba kansarka naasaha oo horumaray kuwaas oo soo-dhoweeyaha Estrogen-ka iyo / ama qaadashada progesterone aan la garanayn

Femara (letrozole) waa nooca II (non-steroidal) inhibitor aromatase jiilka saddexaad.Kiliinik ahaan waxa loo isticmaalaa in lagu daweeyo dumarka postmenopausal ee leh mid ka mid ah reseptor-ka estrogen positive ama reseptor-ka estrogen aan la garanayn kansarka naasaha.

1. Letrozole waa Aromatase Inhibitor awood leh oo loo sameeyay si loola dagaallamo kansarka naasaha.

2. Ciyaartoyda iyo jidh-dhisayaasha, waa daroogo loo isticmaalo si loola dagaallamo dhibaatooyinka estrogenic ee steroids anabolic ee ilaalinta biyaha, finan iyo gynocomastia.

3. Waxa kale oo ay kor u qaadi doontaa heerarka testosterone sababtoo ah hoos u dhaca estrogen ee jirka.

4. Femara (magaca guud waa letrozole) waa daawo cusub oo loo sameeyay daawaynta kansarka naasaha ee haweenka.

5. Femara waa kan labaad ee fasalka cusub ee jiilka saddexaad ee xakameynaya aromatase afka ah.

6. Waxay u shaqeysaa iyadoo xannibaysa aromatase enzyme, ka dibna xannibaysa soo saarista estrogen.

Letrozole/Femara sharraxaadda

Mid ka mid ah maadada baaritaanka lab ee Letrozole wuxuu awooday inuu yareeyo heerarka estrogen ilaa heerar aan la ogaan karin.Letrozole wuxuu awoodaa inuu kor u qaado testosterone ee maadooyinka labka ah.

Letrozole (Femara) waxaa loo isticmaalaa in lagu daweeyo kansarka naasaha ee haweenka postmenopausal.Letrozole waxaa badanaa la siiyaa dumarka qaata tamoxifen (Nolvadex, Soltamox) ilaa 5 sano.Letrozole waa aromatase inhibitor non-steroidal (hoos u dhigista wax soo saarka estrogen).

Letrozole waxaa lagu heli karaa qaab guud.Waxyeellooyinka caadiga ah waxaa ka mid ah bilic kulul, timo lumis, kalagoysyo/lafo/xanuun muruq, daal, dhidid aan caadi ahayn, lallabbo, shuban, dawakhaad, iyo hurdo la'aan.

Qiyaasta lagu taliyey ee Letrozole waa hal kiniin 2.5 mg ah oo la maamulo hal mar maalintii, iyada oo aan loo eegin cuntada.

Daawooyinka kale ayaa laga yaabaa inay la falgalaan Letrozole.U sheeg dhakhtarkaaga dhammaan daawooyinka laguu qoray iyo kuwa aan farmashiyaha laga qorin iyo kaabista aad isticmaashid.Letrozole waa inaan la isticmaalin xilliga uurka.Letrozole waxaa laga yaabaa inay waxyeeleyso uurjiifka.

Letrozole waxaa badanaa loo isticmaalaa dumarka ka dib menopause.Haddii aad dhawaan ku soo martay menopause, kala hadal xakameynta dhalmada dhakhtarkaaga.Ha isticmaalin ka hortagga uurka oo ay ku jirto estrogen.Lama garanayo haddii Letrozole uu u gudbo caanaha naaska oo laga yaabo inuu waxyeello u geysto dhallaanka nuujinta.Naas-nuujinta marka la isticmaalayo Letrozole laguma talinayo.

Qiyaasta Letrozole/Femara ee kansarka naasaha

1: Qiyaasta Caadiga ah ee Qaangaarka ee Kansarka Naasaha:

Si loogu isticmaalo daawaynta safka kowaad ee dumarka postmenopausal ee leh hoormoon reseptor togan ama hoormoon receptor togan oo aan la garanayn meel uu hore u maray ama kansarka naasaha metastatic.Femara ayaa sidoo kale lagu tilmaamay daaweynta kansarka naasaha sare ee haweenka postmenopausal ee leh horumarka cudurka ka dib daaweynta antiestrogen: 2.5 mg kiniin ah oo afka laga qaato hal mar maalintii iyada oo aan loo eegin cuntada.

Bukaannada qaba cudurrada sare, daaweynta Letrozole waa inay sii socotaa ilaa horumarka burada uu ka muuqanayo.

2: Qiyaasta Caadiga ah ee Qaangaarka ee Kansarka Naasaha - Adjuvant:

Si loogu isticmaalo daawaynta adjuvant ee la dheereeyey ee kansarka naasaha hore ee haweenka postmenopausal ee helay 5 sano oo daawaynta adjuvant tamoxifen: 2.5 mg oo kiniin ah ayaa afka laga bixiyaa hal mar maalintii iyada oo aan loo eegin cuntada.

Muddada ugu fiican ee daaweynta Femara lama yaqaan.Daaweynta waa in la joojiyaa haddii ay jirto soo noqoshada buro.

Alaabta Taxanaha Estrogens-ka

Taxanaha Anti-estrogen-ka
Tamoxifen Citrate CAS No.: 563.64
Clomifene citrate CAS No.: 50-41-9
Toremifene Citrate CAS No.: 89778-27-8
Exemestane CAS No.: 107868-30-4
Anastrozole CAS No.: 120511-73-1
Letrozole CAS No.: 112809-51-5
Fulvestrant CAS No.: 129453-61-8

  • Hore:
  • Xiga:

  • Halkan ku qor fariintaada oo noo soo dir